Afficher la couverture 'Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL) | Cottereau, A.S.' en grand format
/5

0 avis

Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)

Archive ouverte

Cottereau, A.S. | Becker, S. | Broussais, F. | Casasnovas, O. | Kanoun, S. | Roques, M. | Charrier, N. | Bertrand, S. | Delarue, R. | Bonnet, C. | Gaulard, P. | Hustinx, R. | de Leval, L. | Vera, P. | Itti, E. | Mounier, N. | Haioun, C. | Tilly, H. | Meignan, M.

Edité par CCSD ; Elsevier -

International audience. Most peripheral T-cell lymphoma (PTCL) patients have a poor outcome and the identification of prognostic factors at diagnosis is needed.

Consulter en ligne

Suggestions

Du même auteur

Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL--Response

Archive ouverte | Cottereau, A.-S. | CCSD

International audience

Metabolic tumor volume predicts outcome in advanced stage follicular lymphoma patients from the Relevance trial.

Archive ouverte | Cottereau, A.S. | CCSD

International audience

Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial

Archive ouverte | Cottereau, A.S. | CCSD

International audience. Background: We investigated the prognostic value of baseline positron emission tomography (PET) parameters for patients with treatment-naïve follicular lymphoma (FL) in the phase III RELEVANC...

Chargement des enrichissements...